Riskpilot← Back to searchSign inGet full accessPharmatest Services Oy
OYActiveY-tunnus 1481682-8Itäinen Pitkäkatu 4-ATechnical testing and analysis · NACE 7120Est. 199817 employeeswww.pharmatest.com
Revenue 2024
EUR 2,6M
+33% vs 2023
EBITDA margin
14.5%
+1729% vs 2023
Equity ratio
20.5%
Financial strength
Net profit 2024
EUR 116K
+161% vs 2023
| Revenue | EUR 2,6M | +33% |
| EBITDA | EUR 381K | +1729% |
| Net profit | EUR 116K | +161% |
| Total assets | EUR 1,2M | -13% |
| Equity | EUR 248K | +451% |
| Employees | 17 | — |
Legal name
Pharmatest Services Oy
Y-tunnus number
1481682-8
Legal form
Osakeyhtiö
NACE code
7120 · Technical testing and analysis
Founded
15. kesäkuuta 1998
Share capital
EUR 80 281
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on lääkinnällisten perustuotteiden, lääkintätuotteiden ja terveyden huoltoon kuuluvien diagnostisten tuotteiden kehittämiseen tähtäävien testausjärjestelmien kehittäminen ja suorittaminen sekä siihen liittyvä tutkimus, tuotekehitys, markkinointi ja konsultointi. Yhtiö voi myös omistaa ja hallita kiinteistöjä, osakkeita ja muita arvopapereita sekä harjoittaa sijoitustoimintaa ja arvopaperikauppaa.
Address
Itäinen Pitkäkatu 4-A
Phone
+358022784700
Email
info@pharmatest.com
Website
www.pharmatest.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 433 | 2 314 | 2 138 | 1 970 | 2 625 |
| Staff expenses | −1 245 | −1 162 | −1 152 | −994 | −1 058 |
| EBITDA | 60 | 101 | 198 | 21 | 381 |
| Depreciation & amort. | −385 | −251 | −253 | −146 | −155 |
| EBIT | −325 | −150 | −55 | −125 | 226 |
| Net financials | −32 | −41 | −52 | −65 | −110 |
| Profit before tax | −277 | −191 | −107 | −190 | 116 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −277 | −191 | −107 | −190 | 116 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 932 | 1 490 | 1 643 | 1 392 | 1 210 |
| Equity | 9 | 42 | 56 | 45 | 248 |
| Long-term debt | 1 108 | 503 | 382 | 293 | 168 |
| Short-term debt | 815 | 945 | 1 206 | 1 054 | 794 |
| Total debt | 1 923 | 1 448 | 1 588 | 1 347 | 962 |
EBITDA margin
14.5%
This company
15.8%
Market median
-8% vs market
20202024
Equity ratio
20.5%
This company
38.2%
Market median
-46% vs market
20202024
Return on equity
46.9%
This company
18.4%
Market median
+155% vs market
20202024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20202024
Asset turnover
2.17×
This company
1.12×
Market median
+94% vs market
20202024
Debt / equity
3.88×
This company
0.62×
Market median
-526% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (3) | ||
JM Chief Executive Officer | Chief Executive Officer | 2017 – 2020 |
JM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2017 – 2020 |
NV Audit | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2018 | |
| Chairperson | 2020 | |
| Former (1) | ||
| Board of Directors | 2019 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmatest Services Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jussi Marko Juhani Halleen | Chief Executive Officer | 0 companies |
| Jenni Maria Bernoulli | Deputy Chief Executive Officer | 0 companies |
| Niklas Vilhelm Oikia | Audit | 0 companies |
| Jukka Pekka Rissanen | Chief Executive Officer | 0 companies |
| Heikki Kalervo Väänänen | Board of Directors | 0 companies |
| Tero Pekka Jaakkola | Board of Directors | 0 companies |
| Joy-Emelié Valentina Wolfram | Board of Directors | 0 companies |
| Pirkko Liisa Härkönen | Board of Directors | 0 companies |
| Mika Juhani Ali-Rantala | Chairperson | 0 companies |